Insidertrades

Aktis Oncology

AKTS

Insider trades and stock quote 2024-2026

All insider trades at Aktis Oncology

Subscribe RSS
Date Type Insider Position Ø-Price Volume
7/20/2026 Sell Herrmann, Ken Director $24.6 $119,274
7/17/2026 Sell Herrmann, Ken Director $25.2 $77,259
7/8/2026 Sell Czibere, Akos Chief Medical Officer $27.9 $1,388,701
7/8/2026 Sell Ron-Bigger, Shulamit Chief Operating Officer $27.9 $1,387,558
1/12/2026 Buy Ecor1 Capital, LLC Director $18.0 $39,999,996
1/12/2026 Buy Kim, Helen Susan Director $18.0 $15,030,000
1/12/2026 Buy Vida Ventures II, LLC Ten Percent Owner $18.0 $15,030,000
1/12/2026 Buy Gadicke, Ansbert Ten Percent Owner $18.0 $20,029,986
1/12/2026 Buy Mpm Bioventures 2018, L.p. Ten Percent Owner $18.0 $20,029,986
1/12/2026 Buy Foley, Todd Director $18.0 $4,191,660
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)